The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 24, 2020
Filed:
Jan. 18, 2019
Taigen Biotechnology Co., Ltd., Taipei, TW;
Ming-chu Hsu, Santa Clara, CA (US);
Chu-Chung Lin, Taipei, TW;
Hung-Chuan Chen, Taipei, TW;
Chiayn Chiang, Taipei, TW;
Chi-Feng Yen, Taipei, TW;
Ming-Chu Hsu, Santa Clara, CA (US);
TaiGen Biotechnology Co., Ltd., Taipei, TW;
Abstract
Provided is a compound of Formula (I) below, or a pharmaceutically acceptable salt, metabolite, or prodrug thereof: wherein: Ais CRor N; Ais CRRor NR; Ais CR'R′ or NR′; each of R, R, R′, R, R′, R, R, R′, R, R′, R, and R′, independently, is hydrogen, deuterium, halogen, cyano, hydroxyl, carboxyl, amino, formyl, nitro, Calkyl, Calkenyl, Calkynyl, Calkoxy, Calkenyloxy, Calkylcarbonyl, Calkyloxycarbonyl, Calkylamine, Ccarbocyclyl, or Cheterocyclyl; or Rand R, R′ and R′, or Rand R′, together with the adjacent atom to which they are each attached, form Ccarbocyclyl or Cheterocyclyl. Further provided are a method of using the above-described compound, or the pharmaceutically acceptable salt, metabolite, or prodrug thereof for treating influenza and a pharmaceutical composition containing same.